Skip to content

The effect of non-surgical periodontal therapy on periodontal status and systemic metabolic status in end-stage renal disease patients

The Effect of Non-Surgical Periodontal Treatment on Systemic Inflammation, Nutritional Status and Lipid level: A Randomized Controlled Trial in End-Stage Renal Disease Patients Undergoing Hemodialysis Therapy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-14005045
Enrollment
Unknown
Registered
2014-07-29
Start date
2010-03-31
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

periodontal disease

Interventions

Treatment group:non-surgical periodontal treatment
Control group:No intervention

Sponsors

Department of Stomatology, Nanfang Hospital, Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
39 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. adults more than 30 years old; 2. All ESRD patients had been undergoing on average 4 h of HD 3 times/wk. All HD patients had a stable status, in the previous two months and with no major complication; 3. a clinical diagnosis of moderate generalized chronic periodontitis (Armitage 1999), presence of more than 16 teeth in the mouth, excluding third molars; 4. had no systemic antibiotic administration within the previous 3 months; 5. and no previous periodontal treatment.

Exclusion criteria

Exclusion criteria: 1. the presence of a systemic disease including diabetes that could influence the course of the periodontal disease; 2. systemic antibiotic administration within the previous 3 months; 3. pregnancy or lactation; 4. an active infection other than periodontitis or had received periodontal treatment in the previous 12 months; 5. Taking medicines influcing the systemic inflammation; 6. hemodialysis treatment less than 6 months; 7. hospitalization, surgery, or renal transplantation within the preceding 3 months; 8. refusal to provide written informed consent.

Design outcomes

Primary

MeasureTime frame
CRP;

Secondary

MeasureTime frame
TNF-alpha;IL-6;ferritin;Alb;BUN;Cr;ALC;Tf;nPCR;TC;TG;HDL-C;LDL-C;

Countries

China

Contacts

Public ContactFuchun Fang
fangfuchun520@163.com+86 15876544748

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026